The use of medium-chain triglycerides in patients with cystic fibrosis
Background. Medium chain triglycerides are absorbed and metabolized faster than long-chain fatty acids, as they bypass the steps necessary for the absorption of long-chain fatty acids. So, they use in various malabsorptive disorders as a source of calories.Objectives. Retrospectively evaluate the cl...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Open Systems Publication
2024-04-01
|
| Series: | Лечащий Врач |
| Subjects: | |
| Online Access: | https://journal.lvrach.ru/jour/article/view/1212 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849404053394554880 |
|---|---|
| author | V. V. Zarubina O. V. Vysokolova M. A. Mukhina Е. E. Yakushina Т. N. Kekeeva |
| author_facet | V. V. Zarubina O. V. Vysokolova M. A. Mukhina Е. E. Yakushina Т. N. Kekeeva |
| author_sort | V. V. Zarubina |
| collection | DOAJ |
| description | Background. Medium chain triglycerides are absorbed and metabolized faster than long-chain fatty acids, as they bypass the steps necessary for the absorption of long-chain fatty acids. So, they use in various malabsorptive disorders as a source of calories.Objectives. Retrospectively evaluate the clinical effectiveness of nutrition supplements (a fat emulsion consisting of medium chain triglycerides), used by patient with cyctic fibrosis.Materials and methods. 39 children with cyctic fibrosis aged 1-17 years were observed at Morozovskaya Children's Clinical Hospital. WHO-Anthro and WHO-Anthro Plus were used to determine their nutritional status.Results. At the beginning of the study, all patients with cyctic fibrosis had a body mass index < 25th percentile. The median percentile of body mass index was 7,8. 0% of patients had a Z-score body mass index > 0.25,6% of patients had a Z-score body mass index from 0 to –1. 51,3% of patients had a Z-score body mass index from –1 to –2.23% of patients had a Z-score body mass index < -2. At the end of the study, 28% of patients with cyctic fibrosis had a body mass index > 25th percentile. The median percentile of body mass index was 16,1. 18% of patients had a Z-score body mass index > 0.38,4% of patients had a Z-score body mass index from 0 to –1.25,6% of patients had a Z-score body mass index from –1 to –2, 18% of patients had a Z-score body mass index < –2.Conclusion. The use medium chain triglycerides could improve nutritional status and alleviate steatorrhea in patient with cyctic fibrosis. |
| format | Article |
| id | doaj-art-7b8fae5a1a284887b0c3b79dc57faf1e |
| institution | Kabale University |
| issn | 1560-5175 2687-1181 |
| language | Russian |
| publishDate | 2024-04-01 |
| publisher | Open Systems Publication |
| record_format | Article |
| series | Лечащий Врач |
| spelling | doaj-art-7b8fae5a1a284887b0c3b79dc57faf1e2025-08-20T03:37:06ZrusOpen Systems PublicationЛечащий Врач1560-51752687-11812024-04-0103959810.51793/OS.2024.27.3.0161200The use of medium-chain triglycerides in patients with cystic fibrosisV. V. Zarubina0O. V. Vysokolova1M. A. Mukhina2Е. E. Yakushina3Т. N. Kekeeva4State Budgetary Healthcare Institution of the city of Moscow Morozovskaya Children's City Clinical Hospital of the Department of Health of the City of MoscowState Budgetary Healthcare Institution of the city of Moscow Morozovskaya Children's City Clinical Hospital of the Department of Health of the City of MoscowState Budgetary Healthcare Institution of the city of Moscow Morozovskaya Children's City Clinical Hospital of the Department of Health of the City of MoscowState Budgetary Healthcare Institution of the city of Moscow Morozovskaya Children's City Clinical Hospital of the Department of Health of the City of MoscowState Budgetary Healthcare Institution of the city of Moscow Morozovskaya Children's City Clinical Hospital of the Department of Health of the City of MoscowBackground. Medium chain triglycerides are absorbed and metabolized faster than long-chain fatty acids, as they bypass the steps necessary for the absorption of long-chain fatty acids. So, they use in various malabsorptive disorders as a source of calories.Objectives. Retrospectively evaluate the clinical effectiveness of nutrition supplements (a fat emulsion consisting of medium chain triglycerides), used by patient with cyctic fibrosis.Materials and methods. 39 children with cyctic fibrosis aged 1-17 years were observed at Morozovskaya Children's Clinical Hospital. WHO-Anthro and WHO-Anthro Plus were used to determine their nutritional status.Results. At the beginning of the study, all patients with cyctic fibrosis had a body mass index < 25th percentile. The median percentile of body mass index was 7,8. 0% of patients had a Z-score body mass index > 0.25,6% of patients had a Z-score body mass index from 0 to –1. 51,3% of patients had a Z-score body mass index from –1 to –2.23% of patients had a Z-score body mass index < -2. At the end of the study, 28% of patients with cyctic fibrosis had a body mass index > 25th percentile. The median percentile of body mass index was 16,1. 18% of patients had a Z-score body mass index > 0.38,4% of patients had a Z-score body mass index from 0 to –1.25,6% of patients had a Z-score body mass index from –1 to –2, 18% of patients had a Z-score body mass index < –2.Conclusion. The use medium chain triglycerides could improve nutritional status and alleviate steatorrhea in patient with cyctic fibrosis.https://journal.lvrach.ru/jour/article/view/1212ystic fibrosisnutritional supportmedium chain triglyceridespancreatic insufficiencysteatorrhea |
| spellingShingle | V. V. Zarubina O. V. Vysokolova M. A. Mukhina Е. E. Yakushina Т. N. Kekeeva The use of medium-chain triglycerides in patients with cystic fibrosis Лечащий Врач ystic fibrosis nutritional support medium chain triglycerides pancreatic insufficiency steatorrhea |
| title | The use of medium-chain triglycerides in patients with cystic fibrosis |
| title_full | The use of medium-chain triglycerides in patients with cystic fibrosis |
| title_fullStr | The use of medium-chain triglycerides in patients with cystic fibrosis |
| title_full_unstemmed | The use of medium-chain triglycerides in patients with cystic fibrosis |
| title_short | The use of medium-chain triglycerides in patients with cystic fibrosis |
| title_sort | use of medium chain triglycerides in patients with cystic fibrosis |
| topic | ystic fibrosis nutritional support medium chain triglycerides pancreatic insufficiency steatorrhea |
| url | https://journal.lvrach.ru/jour/article/view/1212 |
| work_keys_str_mv | AT vvzarubina theuseofmediumchaintriglyceridesinpatientswithcysticfibrosis AT ovvysokolova theuseofmediumchaintriglyceridesinpatientswithcysticfibrosis AT mamukhina theuseofmediumchaintriglyceridesinpatientswithcysticfibrosis AT eeyakushina theuseofmediumchaintriglyceridesinpatientswithcysticfibrosis AT tnkekeeva theuseofmediumchaintriglyceridesinpatientswithcysticfibrosis AT vvzarubina useofmediumchaintriglyceridesinpatientswithcysticfibrosis AT ovvysokolova useofmediumchaintriglyceridesinpatientswithcysticfibrosis AT mamukhina useofmediumchaintriglyceridesinpatientswithcysticfibrosis AT eeyakushina useofmediumchaintriglyceridesinpatientswithcysticfibrosis AT tnkekeeva useofmediumchaintriglyceridesinpatientswithcysticfibrosis |